Related Experiment Video
Updated: Jan 27, 2026

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
Published on: September 16, 2013
Polymyxin B for Gram Negative Multidrug Resistant Bacteria in a Hispanic Population
Rafael De León-Borrás1, Carlos Sánchez-Sergentón1, Angel Mayor-Becerra2
1Division of Infectious Diseases, Department of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico.
Objective:
This study intends to determine the prevalence of multidrug resistant (MDR) infections by A. baumannii, K. pneumoniae and P. aeruginosa in a tertiary care teaching hospital intensive care unit (ICU) in San Juan, PR, estimate the mortality rate and compare the morbidity and mortality differences among those treated with and without polymyxin B.
Methods:
We selected adults patients admitted to the ICU who had positive cultures from January 2012 to June 2013. Sample consisted of 25 patients with age ranges from 27-78 years, 13 women and 12 men.
Results:
The median age at death was 60 years. Polymyxin B nephrotoxicity was identified on 15% of the patients. Variables related to higher survival were younger age, female sex, use of polymyxin B, and the use of daptomycin. The use of vancomycin and vasopressors were associated with worse outcome. Mortality associated to single MDR bacteria was 88% for A. baumannii, 84% for K. pneumoniae and 67% for P. aeruginosa. All patients with more than one MDR infection died in the ICU.
Conclusion:
The use of polymyxin B was associated with an ICU mortality reduction. Unexpectedly we found a significantly improved survival in patients who received polymyxin B in combination with daptomycin, which awaits prospective confirmation.
Insights
Multidrug-resistant (MDR) infections in the ICU, particularly by A. baumannii, K. pneumoniae, and P. aeruginosa, are associated with high mortality. Polymyxin B treatment showed a reduction in ICU mortality, especially when combined with daptomycin.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pharmacology
Background:
- Multidrug-resistant (MDR) bacterial infections pose a significant threat in intensive care units (ICUs).
- Key pathogens include Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
- Limited treatment options exist for MDR infections, necessitating research into effective therapies.
Purpose of the Study:
- To determine the prevalence of MDR infections by A. baumannii, K. pneumoniae, and P. aeruginosa in a tertiary care teaching hospital ICU.
- To estimate the mortality rate associated with these infections.
- To compare morbidity and mortality differences between patients treated with and without polymyxin B.
Main Methods:
- Retrospective study of adult patients admitted to the ICU with positive cultures from January 2012 to June 2013.
- Analysis of patient demographics, treatment regimens, and outcomes.
- Comparison of mortality rates and survival factors between treatment groups.
Main Results:
- High mortality rates were observed for single MDR bacterial infections: 88% for A. baumannii, 84% for K. pneumoniae, and 67% for P. aeruginosa.
- All patients with multiple MDR infections died in the ICU.
- Polymyxin B use was associated with higher survival, as was daptomycin. Vancomycin and vasopressors were linked to worse outcomes. Polymyxin B nephrotoxicity occurred in 15% of patients.
Conclusions:
- Polymyxin B treatment was associated with a reduction in ICU mortality.
- A combination of polymyxin B and daptomycin showed improved survival, warranting further investigation.
- Effective management of MDR infections in ICUs remains a critical challenge.
More Related Videos
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Conservation of Small Populations
What is Population Genetics?
Population Growth
Negative Regulator Molecules
What are Populations and Communities?

